🇺🇸 FDA
Pipeline program

UB-421(25 mg/kg) Q2W

UBP-A209-HIV

Phase 2 mab completed

Quick answer

UB-421(25 mg/kg) Q2W for HIV-1 Infection is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
HIV-1 Infection
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials